INNOCAN PHARMA Corp
INNPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$262 | -$4,700 | -$3,889 | -$10,091 |
| Dep. & Amort. | $33 | $34 | $35 | $43 |
| Deferred Tax | $0 | $0 | -$2,774 | $2,308 |
| Stock-Based Comp. | $2,007 | $854 | $967 | $2,163 |
| Change in WC | -$1,203 | -$808 | -$531 | -$969 |
| Other Non-Cash | -$2,154 | $716 | $125 | -$83 |
| Operating Cash Flow | -$1,579 | -$3,904 | -$6,067 | -$6,629 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$15 | -$46 | -$26 | -$41 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$7 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $69 | -$38 | -$5 | -$0 |
| Investing Cash Flow | $54 | -$84 | -$31 | -$48 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$22 | -$22 | -$11 | -$38 |
| Stock Issued | $891 | $2,993 | $131 | $3,914 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,835 | $2,939 | $136 | $11,427 |
| Financing Cash Flow | $2,704 | $2,917 | $125 | $15,303 |
| Forex Effect | -$56 | $9 | -$128 | $84 |
| Net Chg. in Cash | $1,123 | -$1,062 | -$6,101 | $8,710 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,885 | $4,947 | $11,048 | $2,338 |
| End Cash | $5,008 | $3,885 | $4,947 | $11,048 |
| Free Cash Flow | -$1,594 | -$3,950 | -$6,093 | -$6,670 |